EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis

Leslie Wilson, Katherine E Lewis, Lawrence S Evans, Stacey R Dillon, Kathryn L Pepple

Translational Vision Science & Technology · 2023

DOI: 10.1167/tvst.12.3.27 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2023. Verfasst von Leslie Wilson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Autoimmune Diseases, Uveitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesUveitisRatsHumansAnimalsCD28 AntigensRats, Inbred LewT-LymphocytesRecombinant Fusion Proteins

Substanzen

CD28 AntigensALPN-101Recombinant Fusion Proteins

Autor:innen und Institutionen

  • Department of Ophthalmology, University of Washington, Seattle, WA, USA.
  • Roger and Angie Karalis Johnson Retina Center, University of Washington School of Medicine, Seattle, WA, USA.
  • Discovery Research, Alpine Immune Sciences, Seattle, WA, USA.
  • Translational Medicine, Alpine Immune Sciences, Seattle, WA, USA.

Förderung

  • NIDDK NIH HHS
  • NEI NIH HHS

Zitieren

APA

Wilson, L., Lewis, K. E., Evans, L. S., Dillon, S. R., & Pepple, K. L. (2023). Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.12.3.27

Vancouver

Wilson L, Lewis KE, Evans LS, Dillon SR, Pepple KL. Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis. Translational Vision Science & Technology. 2023. doi:10.1167/tvst.12.3.27

BibTeX
@article{Wilson2023,
  author = {Wilson, Leslie and Lewis, Katherine E and Evans, Lawrence S and Dillon, Stacey R and Pepple, Kathryn L},
  title = {Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis},
  journal = {Translational Vision Science & Technology},
  year = {2023},
  doi = {10.1167/tvst.12.3.27}
}
Kostenlos starten →